Runner's Knee and Honolulu Marathon Training: What the 2026 PRP Evidence Shows

Why this matters right now in Honolulu

The Honolulu Marathon is Hawaii's signature road race, and the 54th running starts at 5:00 a.m. on December 13, 2026, on Ala Moana Boulevard near the Hawaii Convention Center. That means September, October, and November are peak training months for thousands of local runners, from first-timers to veterans chasing personal records through the humidity of the Kaimuki hills and the heat of the Kapiolani Park miles. This is also the window when overuse injuries cluster. The conditions Honolulu physical therapists see most during marathon buildup are Achilles tendinopathy, plantar fasciitis, runner's knee, shin splints, and IT band syndrome, and the usual causes are the same everywhere: repetitive impact, sudden jumps in weekly mileage, footwear that is past its prime, and not enough recovery between hard efforts.

What runner's knee actually is

Runner's knee, technically patellofemoral pain syndrome, is pain around or behind the kneecap that typically builds during or after running, squatting, or going down stairs. The kneecap is supposed to glide smoothly in a groove at the end of the thighbone, and when the muscles around the hip and knee are weak, tight, or firing out of sequence, the tracking becomes slightly off and the joint behind the kneecap gets irritated. The key point for any treatment decision: runner's knee is usually a load and muscle-balance problem before it is a tissue-damage problem, which is why the strongest evidence for managing it starts with strength and training changes, not injections.

The newest PRP evidence for patellofemoral problems

A 2025 systematic review of PRP in patellofemoral arthritis and anterior knee pain pooled results across studies and reported significant improvement: average pain on the visual analog scale dropped from 6.7 to 2.1, and WOMAC scores improved from 24 to 10.3. The same review found no significant change in cartilage on quantitative MRI, and the authors flagged heterogeneous evidence quality across the included trials. A 2026 systematic review of orthobiologics for patellofemoral pathology, covering 9 studies of PRP and stem-cell products, concluded the treatments may hold therapeutic potential but that the evidence remains limited and methodologically varied. A short-term study published in December 2025 in patellofemoral chondromalacia, a form of cartilage softening behind the kneecap, reported that PRP reduced average pain from 6.42 to 1.19 on the VAS at six months and improved anterior knee pain scores. Read together, the evidence says PRP can be helpful, but mostly for people with measurable cartilage change, not as a fix for every aching knee.

“A 2025 systematic review of PRP in patellofemoral arthritis and anterior knee pain found significant pain and functional improvement, but no significant cartilage change on quantitative MRI, with heterogeneous evidence quality.”

The honest limits for a runner

Here is the catch. Nearly all of the recent studies enrolled people with established patellofemoral arthritis or visible cartilage wear, not runners with classic runner's knee on healthy cartilage. As of this writing there is no high-quality randomized trial of PRP specifically for patellofemoral pain in runners, and researchers openly describe the evidence base as small and heterogeneous. For a healthy runner whose knee hurts during the marathon buildup, the best-evidenced first steps remain the unglamorous ones: dialing back mileage, strengthening the glutes and quadriceps, checking footwear and cadence, and working with a physical therapist who builds a gradual return-to-running plan. Most runner's knee resolves with exactly that approach, and jumping to an injection before a real rehab attempt skips the step most likely to help.

When regenerative therapy might be part of the plan

PRP becomes a reasonable conversation when the pain has outlasted a honest rehab block, when imaging shows actual cartilage wear, a tendon problem, or another structural source that matches the symptoms, and when the runner has a clear history of reinjury. In that situation the newest evidence supports discussing PRP as one tool alongside structured rehabilitation, never instead of it, and any responsible clinic will want to confirm the diagnosis with an exam and imaging before recommending an injection. That is the standard we hold ourselves to at Aloha Stem Cell, where Dr. Robert Aki, DPM, brings foot and ankle expertise to the team and our clinicians evaluate every runner's knee on its own merits.

Questions to ask before the Honolulu Marathon buildup

• Has my knee been evaluated with a physical exam, and do I need imaging to see whether there is cartilage wear or a tendon problem?
• Have I tried a structured strength and load-management program first, and for how long?
• If PRP is discussed, what published evidence supports it for my specific findings on imaging?
• What will the injection involve, how many treatments are realistic, and what will it cost?
• How will we track progress, and how will we decide whether it is safe to keep building mileage toward December 13?